299 related articles for article (PubMed ID: 8683364)
21. Polymerase chain reaction amplification of herpes simplex viral DNA from the geniculate ganglion of a patient with Bell's palsy.
Burgess RC; Michaels L; Bale JF; Smith RJ
Ann Otol Rhinol Laryngol; 1994 Oct; 103(10):775-9. PubMed ID: 7944168
[TBL] [Abstract][Full Text] [Related]
22. [Use of double PCR in an experimental mode of HSV-1 infection of the facial nerve].
Carreño M; Llorente J; Melón S; Oña M; Suárez C
Acta Otorrinolaringol Esp; 1999 Oct; 50(7):512-8. PubMed ID: 10619875
[TBL] [Abstract][Full Text] [Related]
23. Demyelination associated with HSV-1-induced facial paralysis.
Wakisaka H; Hato N; Honda N; Takahashi H; Kisaki H; Murakami S; Gyo K; Mominoki K; Kobayashi N; Matsuda S
Exp Neurol; 2002 Nov; 178(1):68-79. PubMed ID: 12460609
[TBL] [Abstract][Full Text] [Related]
24. Role of nitric oxide in the onset of facial nerve palsy by HSV-1 infection.
Hato N; Kohno H; Yamada H; Takahashi H; Gyo K
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1339-42. PubMed ID: 24202866
[TBL] [Abstract][Full Text] [Related]
25. A cell culture model of facial palsy resulting from reactivation of latent herpes simplex type 1.
Kuhn MA; Nayak S; Camarena V; Gardner J; Wilson A; Mohr I; Chao MV; Roehm PC
Otol Neurotol; 2012 Jan; 33(1):87-92. PubMed ID: 22158020
[TBL] [Abstract][Full Text] [Related]
26. [Cause of Bell's palsy: herpes simplex virus].
Mulkens PS; Schirm J
Ned Tijdschr Geneeskd; 1998 Feb; 142(9):438-42. PubMed ID: 9562755
[TBL] [Abstract][Full Text] [Related]
27. Effects of acyclovir on facial nerve paralysis induced by herpes simplex virus type 1 in mice.
Takahashi H; Hato N; Honda N; Kisaki H; Wakisaka H; Matsumoto S; Gyo K
Auris Nasus Larynx; 2003 Feb; 30(1):1-5. PubMed ID: 12589842
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of varicella-zoster virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy.
Furuta Y; Ohtani F; Kawabata H; Fukuda S; Bergström T
Clin Infect Dis; 2000 Mar; 30(3):529-33. PubMed ID: 10722439
[TBL] [Abstract][Full Text] [Related]
29. Bell's palsy and herpes simplex virus.
Vahlne A; Edström S; Arstila P; Beran M; Ejnell H; Nylén O; Lycke E
Arch Otolaryngol; 1981 Feb; 107(2):79-81. PubMed ID: 6258547
[TBL] [Abstract][Full Text] [Related]
30. The alterations of inducible nitric oxide synthase in the mouse brainstem during herpes simplex virus type 1-induced facial palsy.
Mao Y; Fan Z; Han Y; Liu W; Xu L; Jiang Z; Li J; Wang H
Neurol Res; 2012 Apr; 34(3):304-13. PubMed ID: 22449257
[TBL] [Abstract][Full Text] [Related]
31. Bell's palsy associated with herpes simplex gingivostomatitis. A case report.
Nasatzky E; Katz J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Sep; 86(3):293-6. PubMed ID: 9768417
[TBL] [Abstract][Full Text] [Related]
32. The expression of IL-2 and IL-4 in CD4(+) T cells from mouse lymph nodes and spleen during HSV-1-induced facial palsy.
Gu L; Han Y; Liu W; Mao Y; Li J; Wang H
Inflamm Res; 2014 Feb; 63(2):117-25. PubMed ID: 24281729
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus in the saliva of peripheral Bell's palsy patients.
Lazarini PR; Vianna MF; Alcantara MP; Scalia RA; Caiaffa Filho HH
Braz J Otorhinolaryngol; 2006; 72(1):7-11. PubMed ID: 16917546
[TBL] [Abstract][Full Text] [Related]
34. [Serological diagnostic trial of the causative virus of Bell's palsy by anti-herpes virus antibodies in the paired sera].
Chida K; Takase S
Rinsho Shinkeigaku; 2000 Aug; 40(8):791-6. PubMed ID: 11218698
[TBL] [Abstract][Full Text] [Related]
35. Herpes simplex virus type 1 reactivation and antiviral therapy in patients with acute peripheral facial palsy.
Furuta Y; Ohtani F; Chida E; Mesuda Y; Fukuda S; Inuyama Y
Auris Nasus Larynx; 2001 May; 28 Suppl():S13-7. PubMed ID: 11683332
[TBL] [Abstract][Full Text] [Related]
36. [On the viral etiology of Bell's palsy (An enzyme-linked immunosorbent assay study) (author's transl)].
Mees K; Wolf H; Roggendorf M
Laryngol Rhinol Otol (Stuttg); 1981 Dec; 60(12):609-11. PubMed ID: 6285096
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
38. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
[TBL] [Abstract][Full Text] [Related]
39. Possible association of herpes simplex virus infection with demyelinating disease.
Vahlne A; Edström S; Hanner P; Andersen O; Svennerholm B; Lycke E
Scand J Infect Dis Suppl; 1985; 47():16-21. PubMed ID: 3868023
[TBL] [Abstract][Full Text] [Related]
40. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
